Source: NHS Choices
The 'Behind the Headlines' service from NHS Choices has featured a quality assessment of press reports that doctors at Moorfields Eye Hospital have been "given the go-ahead" to carry out Europe's first clinical trial using embryonic stem cells, in patients with Stargardt's macular dystrophy. The assessment addresses the following questions:
. What is Stargardt's disease?
. What are embryonic stem cells?
. How will the trial be performed?
. What is the purpose of the trial?
. When will we know if it has been successful?
Please see (Read more...)